GlassScriptPhysician profile
Manuel J Thomas
NPI 1790870558
$718.05
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2020: $199 · 2022: $47.00.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $171.37 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $74.42 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $63.74 | 2019 | |
| Scilex Pharmaceuticals INC. | $52.81 | 2019-2020 | |
| Eiger Biopharmaceuticals, INC. | $47.00 | 2022 | |
| Lilly USA, LLC | $44.96 | 2020 | |
| Shire North American Group INC | $43.88 | 2019 | |
| Biodelivery Sciences International, INC. | $37.78 | 2019 | |
| Gilead Sciences, INC. | $34.66 | 2019 | |
| Novo Nordisk INC | $27.46 | 2019-2020 | |
| Mdd US Operations, LLC | $25.79 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $24.67 | 2020 | |
| Abbvie INC. | $23.05 | 2019 | |
| Adlon Therapeutics L.P. | $19.09 | 2019 | |
| Indivior INC. | $14.00 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $13.37 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.